Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant

被引:20
|
作者
Parajes, Silvia [1 ]
Gonzalez-Quintela, Arturo [2 ]
Campos, Joaquin [2 ]
Quinteiro, Celsa [1 ]
Dominguez, Fernando [1 ,3 ]
Loidi, Lourdes [1 ]
机构
[1] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain
[2] Hosp Clin Univ, Dept Internal Med, Santiago De Compostela, Spain
[3] Univ Santiago de Compostela, Dept Physiol, Santiago De Compostela, Spain
来源
BMC GENETICS | 2010年 / 11卷
关键词
ANTIMICROBIAL PEPTIDE HEPCIDIN; IRON OVERLOAD; MUTATION NC.-153C-GREATER-THAN-T; EXPRESSION; HEMOCHROMATOSIS; LIVER; INFLAMMATION; HOMEOSTASIS; DEFICIENCY; ABSORPTION;
D O I
10.1186/1471-2156-11-110
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Hepcidin acts as the main regulator of iron homeostasis through regulation of intestinal absorption and macrophage release. Hepcidin deficiency causes iron overload whereas its overproduction is associated with anaemia of chronic diseases. The aims of the study were: to identify genetic variants in the hepcidin gene (HAMP) promoter, to asses the associations between the variants found and iron status parameters, and to functionally study the role on HAMP expression of the most frequent variant. Results: The sequencing of HAMP promoter from 103 healthy individuals revealed two genetic variants: The c.-153C > T with a frequency of 0.014 for allele T, which is known to reduce hepcidin expression and the c.-582A > G with a 0.218 frequency for allele G. In an additional group of 224 individuals, the c.-582A > G variant genotype showed no association with serum iron, transferrin or ferritin levels. The c.-582G HAMP promoter variant decreased the transcriptional activity by 20% compared to c.-582A variant in cells from the human hepatoma cell line HepG2 when cotransfected with luciferase reporter constructs and plasmid expressing upstream stimulatory factor 1 (USF1) and by 12-14% when cotransfected with plasmid expressing upstream stimulatory factor 2 (USF2). Conclusions: The c.-582A > G HAMP promoter variant is not associated with serum iron, transferrin or ferritin levels in the healthy population. The in vitro effect of the c.-582A > G variant resulted in a small reduction of the gene transactivation by allele G compared to allele A. Therefore the effect of the variant on the hepcidin levels in vivo would be likely negligible. Finally, the c.-153C > T variant showed a frequency high enough to be considered when a genetic analysis is done in iron overload patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] The interleukin-6 gene-174G>C and-572G>C promoter polymorphisms are related to cerebral aneurysms
    Morgan, L.
    Cooper, J.
    Montgomery, H.
    Kitchen, N.
    Humphries, S. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (08): : 915 - 917
  • [32] Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk
    Magalhaes, J. F.
    Cortinhas, A. J.
    Albuquerque, C. M.
    Baptista, C. S.
    Ribeiro, R.
    Viegas, Carlos
    Matos, Augusto
    Machado, Joao
    Pires, Maria A.
    Guedes-Pinto, Henrique
    Martins-Bessa, A.
    Leitao, J. C.
    Bastos, E.
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (01) : 449 - 455
  • [33] Functional Variant in Complement C3 Gene Promoter and Genetic Susceptibility to Temporal Lobe Epilepsy and Febrile Seizures
    Jamali, Sarah
    Salzmann, Annick
    Perroud, Nader
    Ponsole-Lenfant, Magali
    Cillario, Jennifer
    Roll, Patrice
    Roeckel-Trevisiol, Nathalie
    Crespel, Ariel
    Balzar, Jorg
    Schlachter, Kurt
    Gruber-Sedlmayr, Ursula
    Pataraia, Ekaterina
    Baumgartner, Christoph
    Zimprich, Alexander
    Zimprich, Fritz
    Malafosse, Alain
    Szepetowski, Pierre
    PLOS ONE, 2010, 5 (09): : 1 - 8
  • [34] A Portuguese patient homozygous for the-25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron
    Porto, G
    Roetto, A
    Daraio, F
    Pinto, JP
    Almeida, S
    Bacelar, C
    Nemeth, E
    Ganz, T
    Camaschella, C
    BLOOD, 2005, 106 (08) : 2922 - 2923
  • [35] Genetic and functional analysis of the VHL tumour suppressor gene promoter
    Morrissey, C
    Zatyka, M
    Latif, F
    Richards, F
    Maher, E
    JOURNAL OF MEDICAL GENETICS, 2000, 37 : S89 - S89
  • [36] Role of the functional variant (-652T>G) in the XRCC4 promoter in prostate cancer
    Shao, Ning
    Li, JiuMing
    Xu, Bin
    Wang, Yang
    Lu, XiaoJie
    Feng, NingHan
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (11) : 7463 - 7470
  • [37] Association of c.461G>A genetic variant of OGG1 gene with pancreatic cancer susceptibility in Chinese
    Zhao, Z. M.
    Li, C. G.
    Hu, M. G.
    Zhao, G. D.
    Liu, R.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 7256 - 7261
  • [38] ROLE OF THE FUNCTIONAL VARIANT (-652 T>G) IN THE XRCC4 PROMOTER IN PROSTATE CANCER
    Feng, Ninghan
    Shao, Ning
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A220 - A220
  • [39] A Novel Mutation in the Promoter Region of the -Globin Gene: HBB: c.-127G>C
    Bilgen, Turker
    Canatan, Duran
    Delibas, Serpil
    Keser, Ibrahim
    HEMOGLOBIN, 2016, 40 (04) : 280 - 282
  • [40] Influence of the c.1517G>C genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population
    Zhao, Z. M.
    Li, C. G.
    Hu, M. G.
    Gao, Y. X.
    Liu, R.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 4466 - 4472